Literature DB >> 33980757

Brain-derived Neurotrophic Factor in the Aqueous Humor of Glaucoma Patients.

Tsutomu Igarashi1, Kenji Nakamoto1, Maika Kobayashi1, Hisaharu Suzuki1, Takeshi Arima1, Yutaro Tobita1, Kazuhiro Takao1, Toru Igarashi2, Takahisa Okuda3, Takashi Okada4, Hiroshi Takahashi1.   

Abstract

BACKGROUND: Brain-derived neurotrophic factor (BDNF) may be involved in the pathogenesis of glaucoma. BDNF concentrations reported in previous studies have varied widely, and the concentration of BDNF in aqueous humor is unknown. In this study, BDNF concentrations in the aqueous humor of glaucoma patients and control patients were measured with ELISA kits.
METHODS: This prospective, observational study examined BDNF levels in aqueous humor in 62 eyes of 43 patients who underwent cataract surgery or trabeculectomy (11 glaucoma patients and 32 non-glaucoma cataract patients as controls). BDNF concentrations were examined by 4 different enzyme-linked immunosorbent assay (ELISA) techniques.
RESULTS: The mean ± SD patient age was 72.0 ± 10.1 (range 35 to 87) years. Two of the techniques detected no BDNF in aqueous humor in any samples (n=3 and n=9, respectively); the average value was less than zero. An ultrasensitive ELISA kit did not yield reliable measurements. Finally, in an even more sensitive ELISA (Simoa-HD1), performed by an outside contractor, 25 (54.3%) eyes were below the detection limit, including 20 (55.6%) control and 5 (50%) glaucoma cases. For eyes with detectable BDNF, the overall BDNF concentration was 0.158 pg/mL (n=21): 0.196 pg/mL (n=16) in controls and 0.034 pg/mL (n=5) in glaucoma cases.
CONCLUSIONS: BDNF level in aqueous humor varies widely.

Entities:  

Keywords:  BDNF; anterior chamber; aqueous humor; brain-derived neurotrophic factor; glaucoma

Year:  2021        PMID: 33980757     DOI: 10.1272/jnms.JNMS.2021_88-305

Source DB:  PubMed          Journal:  J Nippon Med Sch        ISSN: 1345-4676            Impact factor:   0.920


  2 in total

Review 1.  Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art.

Authors:  Lidawani Lambuk; Mohd Aizuddin Mohd Lazaldin; Suhana Ahmad; Igor Iezhitsa; Renu Agarwal; Vuk Uskoković; Rohimah Mohamud
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

2.  Citicoline/Coenzyme Q10/Vitamin B3 Fixed Combination Exerts Synergistic Protective Effects on Neuronal Cells Exposed to Oxidative Stress.

Authors:  Leonardo Mastropasqua; Luca Agnifili; Claudio Ferrante; Matteo Sacchi; Michele Figus; Gemma Caterina Maria Rossi; Lorenza Brescia; Raffaella Aloia; Giustino Orlando
Journal:  Nutrients       Date:  2022-07-20       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.